Literature DB >> 12232863

Microwave ablation for surgical treatment of atrial fibrillation.

Mathew R Williams1, Michael Argenziano, Mehmet C Oz.   

Abstract

Microwave energy is a relatively new energy modality that is being used for surgical atrial ablation as a treatment of atrial fibrillation. Microwave energy works by dielectric heating and has a favorable thermal profile that permits both rapid endocardial and epicardial ablation. The device is also extremely flexible and can be easily adapted to minimally invasive applications. The device has been used in over 600 patients with a success ranging from 70% to 90% and without any device-related complications. Many of these patients have had their ablations performed from the epicardium on the beating heart without the aid of cardiopulmonary bypass. Microwave atrial ablation is likely to become an important part of the surgical armamentarium, particularly for those performing minimally invasive approaches to cure atrial fibrillation. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12232863     DOI: 10.1053/stcs.2002.35289

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  4 in total

1.  Laser Ablation Of Atrial Fibrillation: Mid-term Clinical Experience.

Authors:  Li Poa; Miguel Puig; Pablo Zubiate; Edward Ranzenbach; Miller Shari-Knutson; Christina Poa; Hyunah Poa
Journal:  J Atr Fibrillation       Date:  2009-08-01

2.  Alternative energy sources for surgical treatment of atrial fibrillation in patients undergoing mitral valve surgery: microwave ablation vs cryoablation.

Authors:  Joon Bum Kim; Won-Chul Cho; Sung Ho Jung; Cheol Hyun Chung; Suk Jung Choo; Jae Won Lee
Journal:  J Korean Med Sci       Date:  2010-09-17       Impact factor: 2.153

Review 3.  Surgical ablation devices for atrial fibrillation.

Authors:  Shelly C Lall; Ralph J Damiano
Journal:  J Interv Card Electrophysiol       Date:  2007-12       Impact factor: 1.900

4.  Surgical therapy of atrial fibrillation.

Authors:  Martin Haensig; Ardawan Julian Rastan; David Michael Holzhey; Friedrich-Wilhelm Mohr; Jens Garbade
Journal:  Cardiol Res Pract       Date:  2012-03-25       Impact factor: 1.866

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.